Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

NCT01328626

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 52902 Tucson, Arizona, United States
  • Ucsd /Id# 48325 La Jolla, California, United States
  • Dana-Farber Cancer Institute /ID# 48324 Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center /ID# 56810 New York, United States
View Trial Details
Completed

Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL

NCT02987400

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie Graz, Austria
  • Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin V Hämatologie und Onkologie Innsbruck, Austria
  • Kepler Universitätsklinikum Linz, Med Campus III.,Univ.-Klinik für Hämatologie und Internistische Onkologie Linz, Austria
  • Universitätsklinik für Innere Med. III, PMU Salzburg Salzburg, Austria
View Trial Details

Related conditions